Clinical Trial Update: Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the topical safety and tolerability of Albuterol Sulfate Acu-30 DPI in allergic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Albuterol Sulfate Acu-30 DPI (albuterol sulfate)

Snippet

Sponsor: Respirics Inc. | Conditions: Allergic Asthma | Phase 1 | Status: COMPLETED